Accessing cancer metabolic pathways by the use of microarray technology

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Cancer cells exhibit altered glycolysis (Warburg effect) and increased dependence on glucose and glutamine.
• This metabolic reprogramming presents a therapeutic vulnerability for targeted anti-cancer drug development.

Purpose of the Study:

• To review the utility of microarray technology in integrating cancer metabolism and transcriptomic data.
• To explore the potential of these integrated approaches for developing novel cancer therapies and personalized medicine.

Main Methods:

• Review of microarray technology from its early stages to modern bioinformatics and systems biology applications.
• Integration of metabolic and transcriptomic data, alongside clinicopathological information.

Main Results:

• Microarray technology can effectively integrate multi-layered biological information, including cancer metabolism and gene expression.
• Identified potential new targets in cancer metabolism for novel therapeutic strategies.

Conclusions:

• Combining cancer metabolism insights with transcriptomic analysis via microarrays is a promising strategy for developing targeted cancer therapies.
• This approach facilitates the establishment of personalized medicine by informing clinical decision-making with custom microarray platforms.